Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC

Condition:   Locally Advanced Non-Small Cell Lung Cancer Interventions:   Drug: Atovaquone Oral Suspension;   Drug: Standard of care chemotherapy;   Radiation: Standard of care radiotherapy Sponsors:   University of Oxford;   Cancer Research UK;   National Institute for Health Research, United Kingdom;   NHS Lothian;   Oxford University Hospitals NHS Trust;   NHS Research Scotland Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials